Skip to main content
Clinical Trials/CTRI/2020/05/025174
CTRI/2020/05/025174Not yet recruitingNot Applicable

A clinico-comparative study of Rasnadi Churna and Chaturbija Churna in the management of Janusandhigata Vata

Government Akhandanand Ayurved Mahavidhyalaya Bhadra Ahmedabad1 site in 1 country30 target enrollmentStarted: May 17, 2020Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Result will be assessed on the basis of relief signs and symptoms of Janusandhigata vata

Study Overview

Brief Summary

To study the clinico-comparative effect of Rasnadi Churna and Chaturbija Churna in themanagement of Janusandhigata Vata.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Open Label

Eligibility Criteria

Ages
30.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Chronicity up to 5 years.
  • Traumatic arthritis.
  • Patients having sign and symptoms of Janusandhigata Vata with fulfilling the diagnostic criteria.

Exclusion Criteria

  • Age below 30 years and above 70 years.
  • Patient suffering from Vatarkta, Amavata, systemic lupus erythmetus(SLE), Psoriatic arthritis,infective arthritis and other systemic serious disorders will be excluded.

Outcomes

Primary Outcomes

Result will be assessed on the basis of relief signs and symptoms of Janusandhigata vata

Time Frame: 4 weeks

Secondary Outcomes

  • By comparing the effect of both drugs in the management of Janusandhigata Vata(4 weeks)

Investigators

Sponsor
Government Akhandanand Ayurved Mahavidhyalaya Bhadra Ahmedabad
Sponsor Class
Government medical college

Study Sites (1)

Loading locations...

Similar Trials